Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EBI-005
DRUG
2 trials
Sponsors
Eleven Biotherapeutics
Conditions
Allergic Conjunctivitis (AC)
Dry Eye
Phase 3
Study of EBI-005 in Dry Eye Disease (DED)
NCT02405039
Eleven Biotherapeutics
Dry Eye
Start: 2015-04-30
End: 2016-07-31
Target: 188
Updated: 2015-06-04
A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis
Completed
NCT02492321
Eleven Biotherapeutics
Allergic Conjunctivitis (AC)
Start: 2015-07-31
End: 2015-12-31
Updated: 2016-02-11